Figure 1.
Assessment of ANXA1 levels in patients with type-2 diabetes. (A) Plasma ANXA1 levels measured by ELISA in age and sex match normoglycemic (n = 30) and patients with type-2 diabetes (n = 65). (B) Correlation in diabetic patients of plasma ANXA1 levels and: Fatty Liver Index (B), LDL-C (C), and total cholesterol (D). Data is expressed as mean± SEM., ****p < 0.0001. (B–D) 95% confidence intervals are displayed of the microvascular and significance estimated using Fishers F-test p < 0.05 was deemed significant.